LINKAGE STUDIES IN A KINDRED WITH HYPOCALCIURIC HYPERCALCEMIA AND INCREASING SERUM PARATHYROID-HORMONE LEVELS INDICATE GENETIC-HETEROGENEITY

LINKAGE STUDIES IN A KINDRED WITH HYPOCALCIURIC HYPERCALCEMIA AND INCREASING SERUM PARATHYROID-HORMONE LEVELS INDICATE GENETIC-HETEROGENEITY

Detalhes bibliográficos
Principais autores:	Trump, D, Whyte, M, Wooding, C, Pang, J, Kocher, D, Thakker, R
Formato:	Journal article
Publicado em:	1993

Registros relacionados

LINKAGE STUDIES IN A KINDRED FROM OKLAHOMA WITH FAMILIAL BENIGN HYPOCALCIURIC HYPERCALCEMIA (FBH) INDICATE GENETIC-HETEROGENEITY AND A 3RD LOCUS FOR FBH
por: Trump, D, et al.
Publicado em: (1995)

Linkage studies in a kindred from Oklahoma, with familial benign (hypocalciuric) hypercalcaemia (FBH) and developmental elevations in serum parathyroid hormone levels, indicate a third locus for FBH.
por: Trump, D, et al.
Publicado em: (1995)

LINKAGE STUDIES IN A KINDRED WITH AUTOSOMAL-DOMINANT SPONDYLOEPIMETAPHYSEAL DYSPLASIA (SEMD) INDICATE GENETIC-HETEROGENEITY
por: Gertner, J, et al.
Publicado em: (1995)

Linkage studies of a Missouri kindred with autosomal dominant spondyloepimetaphyseal dysplasia (SEMD) indicate genetic heterogeneity.
por: Gertner, J, et al.
Publicado em: (1997)

Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3
por: Nesbit, M, et al.
Publicado em: (2013)

Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3.
por: Nesbit, M, et al.
Publicado em: (2013)

Identification of a second kindred with familial hypocalciuric hypercalcemia type 3 (FHH3) narrows localization to a <3.5 megabase pair region on chromosome 19q13.3.
por: Nesbit, M, et al.
Publicado em: (2010)

Cinacalcet reverses short QT Interval in familial hypocalciuric hypercalcemia type 1
por: Cuny, T, et al.
Publicado em: (2023)

Neonatal hypocalcemic seizures in offspring of a mother with familial hypocalciuric hypercalcemia type 1 (FHH1)
por: Dharmaraj, P, et al.
Publicado em: (2020)

Cinacalcet rectifies hypercalcemia in a patient with familial hypocalciuric hypercalcemia type 2 (FHH2) caused by a germline loss‐of‐function Gα11 mutation
por: Gorvin, C, et al.
Publicado em: (2017)

Calcium-sensing receptor mutations in familial hypocalciuric hypercalcaemia with recurrent pancreatitis.
por: Pearce, S, et al.
Publicado em: (1996)

Familial hypocalciuric hypercalcemia type 1 and autosomal-dominant hypocalcemia type 1: prevalence in a large healthcare population
por: Dershem, R, et al.
Publicado em: (2020)

Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism.
por: Pearce, S, et al.
Publicado em: (1995)

Seven novel mutations in the PEX gene indicate molecular heterogeneity for X-linked hypophosphataemic rickets.
por: Dixon, P, et al.
Publicado em: (1996)

Recombinant human parathyroid hormone.
por: Reeve, J
Publicado em: (2002)

A G-protein subunit-α11 loss-of-function mutation, Thr54Met, causes familial hypocalciuric hypercalcemia type 2 (FHH2)
por: Gorvin, C, et al.
Publicado em: (2016)

Loss of heterozygosity studies at the retinoblastoma and breast cancer susceptibility (BRCA2) loci in pituitary, parathyroid, pancreatic and carcinoid tumours.
por: Pearce, S, et al.
Publicado em: (1996)

Recombinant human parathyroid hormone - Reply
por: Reeve, J
Publicado em: (2002)

ILLEGITIMATE TRANSCRIPTION OF THE PARATHYROID-HORMONE GENE IN LYMPHOCYTES FROM NORMAL AND HYPOPARATHYROID INDIVIDUALS
por: Parkinson, D, et al.
Publicado em: (1992)

Genetics of parathyroid tumours
por: Thakker, R
Publicado em: (2016)

SIKs control osteocyte responses to parathyroid hormone
por: Wein, Marc N., et al.
Publicado em: (2017)

Suggestive linkage of the parathyroid receptor type 1 to osteoporosis.
por: Duncan, E, et al.
Publicado em: (1999)

Suggestive linkage of the parathyroid receptor type 1 to osteoporosis
por: Duncan, E, et al.
Publicado em: (1999)

Localization of familial benign hypercalcemia, Oklahoma variant (FBHOk), to chromosome 19q13.
por: Lloyd, SE, et al.
Publicado em: (1999)

A donor splice site mutation in the parathyroid hormone gene is associated with autosomal recessive hypoparathyroidism.
por: Parkinson, D, et al.
Publicado em: (1992)

THE PATHO-PHYSIOLOGY OF HYPERCALCEMIA
por: Kanis, J, et al.
Publicado em: (1980)

Molecular genetics of parathyroid disease
por: Thakker, R
Publicado em: (1996)

Parathyroid hormone - a bone anabolic and catabolic agent.
por: Poole, K, et al.
Publicado em: (2005)

X-linked hypophosphataemic rickets in a Saudi Arabian kindred results from a nonsense mutation of the PEX gene.
por: Dixon, P, et al.
Publicado em: (1997)

Parathyroid hormone gene analysis in autosomal hypoparathyroidism using an intragenic tetranucleotide (AAAT)n polymorphism.
por: Parkinson, D, et al.
Publicado em: (1993)

Genetic mapping studies of familial benign hypercalcemia type 3 (FBH3) on chromosome 19q13.
por: Cianferotti, L, et al.
Publicado em: (1999)

Genetic contribution to bone metabolism, calcium excretion, and vitamin D and parathyroid hormone regulation.
por: Hunter, D, et al.
Publicado em: (2001)

Genetics of endocrine and metabolic disorders: parathyroid.
por: Thakker, R
Publicado em: (2004)

Severe hypercalcaemia from secretion of parathyroid hormone-related peptide.
por: Barakat, M, et al.
Publicado em: (2004)

In vivo and in vitro characterization of neonatal hyperparathyroidism resulting from a de novo, heterozygous mutation in the Ca2+-sensing receptor gene: normal maternal calcium homeostasis as a cause of secondary hyperparathyroidism in familial benign hypocalciuric hypercalcemia.
por: Bai, M, et al.
Publicado em: (1997)

GNA11 variants identified in patients with hypercalcemia or hypocalcemia
por: Howles, S, et al.
Publicado em: (2023)

The molecular basis of parathyroid tumours in multiple endocrine neoplasia type 1
por: Thakker, R, et al.
Publicado em: (1990)

Parathyroid hormone-related protein is reduced in severe chronic heart failure.
por: Giannakoulas, G, et al.
Publicado em: (2006)

Economic evaluation of parathyroid hormone (PTH) in the treatment of osteoporosis in postmenopausal women.
por: Lundkvist, J, et al.
Publicado em: (2006)

Cinacalcet for Symptomatic Hypercalcemia Caused by AP2S1 Mutations
por: Howles, S, et al.
Publicado em: (2016)